{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:57:03Z","timestamp":1726513023408},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.transproceed.2018.07.015","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:27:30Z","timestamp":1531268850000},"page":"3483-3486","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic Plasma Exchange in Pediatric Renal Transplantation Experience of One Decade and 389 Sessions"],"prefix":"10.1016","volume":"50","author":[{"given":"D.","family":"Runowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Prokurat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rubik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Grenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.07.015_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.transproceed.2018.07.015_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jca.21221","article-title":"Plasma exchange for renal disease: evidence and use 2011","volume":"27","author":"Clark","year":"2012","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.transproceed.2018.07.015_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12882-016-0322-7","article-title":"The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series","volume":"17","author":"Kashgary","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.015_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/petr.12185","article-title":"Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients","volume":"18","author":"Straatman","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2018.07.015_bib5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00431-016-2747-1","article-title":"Rituximab is not a \u201cmagic drug\u201d in post-transplant recurrence of nephrotic syndrome","volume":"175","author":"Grenda","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.transproceed.2018.07.015_bib6","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1111\/j.1399-3046.2010.01303.x","article-title":"Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation","volume":"15","author":"Grenda","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2018.07.015_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1399-3046.2011.01478.x","article-title":"Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation","volume":"15","author":"Gonzalez","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2018.07.015_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.015_bib9","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-011-1944-4","article-title":"Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations","volume":"26","author":"Kim","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.015_bib10","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2215\/CJN.10181110","article-title":"Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome","volume":"6","author":"Nester","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.015_bib11","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1111\/petr.12537","article-title":"Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1\/CFHR3 gene mutation-associated HUS","volume":"19","author":"Grenda","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2018.07.015_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/trf.12923","article-title":"Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients","volume":"55","author":"Yamada","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transproceed.2018.07.015_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A\u00a0comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.015_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study","volume":"98","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.07.015_bib15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.07.015_bib16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-009-1386-4","article-title":"Advances in diagnosing and managing antibody-mediated rejection","volume":"25","author":"Jordan","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2018.07.015_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/TP.0000000000000244","article-title":"Indicators of treatment responsiveness\u00a0to rituximab and plasmapheresis in antibody mediated rejection after kidney transplantation","volume":"99","author":"Immenschuh","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.07.015_bib18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/petr.12828","article-title":"Eltrombopag (thrombopoietin-receptor agonist) and plasmapheresis as rescue therapy of acute post-renal transplant immune thrombocytopenia in a child with Schimke immuno-osseous dysplasia -case report","volume":"20","author":"Grenda","year":"2016","journal-title":"Pediatr Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518309412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518309412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T02:30:42Z","timestamp":1720405842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518309412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0041134518309412"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.07.015","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Plasma Exchange in Pediatric Renal Transplantation Experience of One Decade and 389 Sessions","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}